Chronic Regulation of miR-124-3p in the Perilesional Cortex after Experimental and Human TBI

Niina Vuokila1, Eleonora Aronica2,3, Anatoly Korotkov2

  • 1A. I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland.

Insights

Traumatic brain injury (TBI) causes persistent downregulation of miR-124-3p in the brain. This microRNA dysregulation may contribute to neuroinflammation and neurodegeneration after TBI.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key gene regulators, and their dysregulation is implicated in Traumatic Brain Injury (TBI).
  • miR-124-3p is a brain-enriched miRNA associated with post-TBI pathologies like neuroinflammation.

Purpose of the Study:

  • To investigate the changes in miR-124-3p expression in the perilesional cortex following TBI.
  • To identify miR-124-3p targets and assess their relevance in the TBI context.
  • To determine if miR-124-3p downregulation in TBI is conserved in human brain tissue.

Main Methods:

  • Quantitative reverse transcription PCR (RT-qPCR) to measure miR-124-3p and target gene expression in rat brain tissue.
  • In situ hybridization to localize miR-124-3p expression in rat and human brain samples.
  • Messenger RNA sequencing (mRNA-Seq) to identify global changes in miR-124-3p targets.

Main Results:

  • miR-124-3p was significantly downregulated in the perilesional cortex of rats at 7 days and 3 months post-TBI.
  • The miR-124-3p target, Stat3, was upregulated at 7 days post-TBI.
  • mRNA-Seq identified hundreds of downregulated and upregulated miR-124-3p targets.
  • Human autopsy samples showed reduced miR-124-3p expression in cortical neurons after TBI.

Conclusions:

  • TBI induces persistent downregulation of miR-124-3p in the perilesional cortex.
  • This miRNA dysregulation may play a role in the neurodegenerative and neuroinflammatory processes following TBI.
  • Findings in rats translate to human TBI patients, highlighting miR-124-3p as a potential therapeutic target.

Related Concept Videos